Executive Summary
Texas Instruments delivered 13% revenue growth to $17.68 billion and expanded free cash flow significantly to $2.94 billion (16.6% of revenue), but operating margin compressed to 34.1% from 34.9% due to elevated manufacturing costs from ongoing capacity expansion. The company is nearing the end of its elevated capex cycle and announced a $7.5 billion acquisition of Silicon Labs.
What happened
Texas Instruments reported full-year 2025 revenue of $17.68 billion, up 13.0% from $15.64 billion in 2024, driven by increased demand in both Analog and Embedded Processing segments. The analog semiconductor market recovery continued, though at a slower pace than prior upturns, influenced by macroeconomic uncertainty. Despite revenue growth, gross profit margin compressed to 57.0% from 58.1% as higher manufacturing costs from planned capacity expansions more than offset benefits from increased factory loadings. Operating profit reached $6.02 billion, representing 34.1% of revenue compared with 34.9% in the prior year. Net income rose to $5.00 billion from $4.80 billion, and EPS increased to $5.45 from $5.20. Cash flow from operations improved to $7.15 billion from $6.32 billion, while free cash flow nearly doubled to $2.94 billion from $1.50 billion as capital expenditures moderated. The effective tax rate increased to 12.4% from 12.0% due to the One Big Beautiful Bill Act (OBBBA) enacted July 4, 2025, though future tax rates are expected to be lower. The company returned $6.48 billion to shareholders through $5.00 billion in dividends and $1.48 billion in share repurchases.
Why it matters for investors
The results demonstrate that Texas Instruments' business model is delivering revenue growth as end-market demand recovers, but the margin trajectory reveals the near-term cost of the company's strategic capacity expansion. The compression in gross margin from 58.1% to 57.0% and operating margin from 34.9% to 34.1% reflects the burden of fixed manufacturing costs associated with new facilities that are still ramping production. The LFAB facility, which supports Embedded Processing, is in early ramp stages and is disproportionately affecting that segment's profitability, as evidenced by the 260-basis-point decline in Embedded Processing operating margin to 11.3% despite revenue growth. The sharp improvement in free cash flow from $1.50 billion to $2.94 billion signals that the capital intensity is beginning to moderate, and the guided reduction in 2026 capital expenditures to $2-3 billion from $4.55 billion marks an inflection point toward normalized investment levels. This transition should allow operating leverage to return as revenue spreads across the expanded capacity base. The announced Silicon Labs acquisition for approximately $7.5 billion represents a significant deployment of capital and indicates management's confidence in the analog and embedded market opportunity. The company's exposure to China—representing 20% of revenue by customer headquarters and 50% by shipment destination—creates ongoing geopolitical risk from trade restrictions and tariffs that could affect demand and supply chain access.
Bullish points
Free cash flow nearly doubled to $2.94 billion from $1.50 billion, with free cash flow margin expanding to 16.6% from 9.6%, reflecting the benefits of moderating capital intensity as the company nears the end of its six-year elevated capex cycle.
Capital expenditures are expected to decline sharply to $2-3 billion in 2026 from $4.55 billion in 2025, which should enable stronger cash generation and improved returns to shareholders while the revenue base continues to expand.
The CHIPS Act is expected to provide increasing benefits with a 35% investment tax credit available for qualifying manufacturing investments placed in service after December 31, 2025, plus direct funding of up to $1.6 billion for three large-scale 300mm wafer fabs, which will reduce the effective cost of the capacity buildout.
Analog segment operating margin expanded to 38.6% from 37.9% despite broader company margin pressure, demonstrating the segment's ability to leverage revenue growth as its primary product line shows healthy 15% growth.
Bearish points
Operating margin compressed to 34.1% from 34.9% and gross margin fell to 57.0% from 58.1% due to higher manufacturing costs from capacity expansion that outpaced the benefit of increased factory loadings, indicating that profitability is under pressure from the fixed cost structure.
Embedded Processing operating margin declined sharply to 11.3% from 13.9% despite 6% revenue growth, reflecting disproportionate manufacturing costs from the LFAB facility that is in early ramp stages and will continue to weigh on profitability until production scales.
Total cash declined to $4.88 billion from $7.58 billion, driven by $6.48 billion returned to shareholders and capital deployment, which reduces financial flexibility ahead of the $7.5 billion Silicon Labs acquisition expected to close in the first half of 2027.
The effective tax rate increased to 12.4% from 12.0% in 2025 due to the OBBBA legislation enacted July 4, 2025, and while future tax rates are expected to be lower, the near-term effect reduced profitability.
Revenue from customers headquartered in China represented approximately 20% of total revenue, and products shipped into China represented approximately 50% of revenue, creating substantial exposure to geopolitical tensions, tariffs, and export restrictions that could limit market access or prompt customers to seek alternate suppliers.
Key highlights
Texas Instruments' 2025 results reflect the dual dynamics of demand recovery and capacity expansion costs. Revenue of $17.68 billion grew 13.0% with strong performance in Analog (15% growth) and moderate growth in Embedded Processing (6% growth). The Analog segment maintained strong profitability with operating margin expansion to 38.6% from 37.9%, while Embedded Processing margin contracted to 11.3% from 13.9% due to costs from the ramping LFAB facility. Operating profit increased to $6.02 billion but margin compressed to 34.1% from 34.9% as manufacturing costs from capacity expansion exceeded benefits from higher factory loadings. Free cash flow nearly doubled to $2.94 billion (16.6% of revenue) from $1.50 billion (9.6% of revenue) as capital expenditures moderated to $4.55 billion from $4.82 billion. The company returned $6.48 billion to shareholders through $5.00 billion in dividends and $1.48 billion in share repurchases. Capital expenditures are expected to decline to $2-3 billion in 2026, marking the end of a six-year elevated investment cycle. CHIPS Act benefits included $335 million in cash in 2025, with a 35% investment tax credit available for assets placed in service after December 31, 2025, and up to $1.6 billion in direct funding committed for three 300mm fabs. The company announced a definitive agreement on February 4, 2026, to acquire Silicon Labs for $231 per share in an all-cash transaction valued at approximately $7.5 billion, expected to close in the first half of 2027.
Management commentary
Management stated that the strategic focus remains on analog and embedded processing products, with emphasis on industrial, automotive, and data center markets, which represent the best long-term growth opportunities. Management noted that in 2025, the overall analog and embedded semiconductor market recovery continued, though at a slower pace than prior upturns, likely related to broader macroeconomic dynamics and overall uncertainty, while global semiconductor shipments remain below prior peak levels. Management explained that fixed manufacturing costs do not decline with reductions in customer demand or factory loadings and can adversely affect profit margins, and noted that with capacity expansions, capital expenditures and depreciation have increased. Management highlighted that the LFAB facility, which primarily supports Embedded Processing, was purchased as an operating fab and is in the early stages of ramping, and stated that until LFAB ramps, Embedded Processing is expected to carry manufacturing costs that disproportionately affect operating profit compared to Analog. Management disclosed that the company is nearing the end of its six-year elevated capital expenditures cycle and expects to spend about $2 billion to $3 billion in 2026, with capital expenditures beyond 2026 dependent on revenue and growth expectations. Management noted that for 2026 and beyond, the effective tax rate and tax-related cash payments are expected to be lower than they would have been under prior tax law due to the OBBBA enacted July 4, 2025. Management affirmed that the ultimate objective and the best metric for owners to measure progress is through the growth of free cash flow per share over the long term.
What to watch next
Investors should monitor:
The ramp trajectory of the LFAB facility and its impact on Embedded Processing segment profitability, as management indicated it will disproportionately affect operating profit until production scales.
The execution of the capital expenditure reduction to $2-3 billion in 2026 from $4.55 billion in 2025, which will determine the pace of free cash flow expansion as the company transitions from capacity buildout to normalized investment levels.
The timing and conditions of the Silicon Labs acquisition closing, expected in the first half of 2027, and the impact of the approximately $7.5 billion all-cash transaction on leverage and capital allocation priorities.
The realization of CHIPS Act benefits, including the 35% investment tax credit on qualifying manufacturing investments placed in service after December 31, 2025, and the receipt of up to $1.6 billion in direct funding for three 300mm wafer fabs.
The pace of analog and embedded semiconductor market recovery and whether it continues at the slower rate observed in 2025, given macroeconomic uncertainty and the fact that global semiconductor shipments remain below prior peak levels.
This summary is based solely on excerpts from the company's Form 10-K filing.
